FIBROGEN INC·4

Mar 25, 9:00 AM ET

Wettig Thane 4

4 · FIBROGEN INC · Filed Mar 25, 2025

Insider Transaction Report

Form 4
Period: 2025-03-24
Wettig Thane
DirectorCEO
Transactions
  • Purchase

    Common Stock

    2025-03-24$0.35/sh+145,000$50,663543,329 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,000
Footnotes (1)
  • [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    form4-03252025_090301.xmlPrimary